Noninvasive imaging of cardiovascular injury related to the treatment of cancer

JACC: Cardiovascular Imaging

Volumn 7, Issue 8, 2014, Pages 824-838

  Kongbundansuk, Suwat ^a   Hundley, W Gregory ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular imaging; chemotherapy related cardiotoxicity; noninvasive imaging

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; LIPOCORTIN 5;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INJURY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CELL DEATH; CHEMOTHERAPY; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HUMAN; IMAGING; INFLAMMATION; MORBIDITY; NON INVASIVE IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; MORTALITY; MULTIMODAL IMAGING; NEOPLASMS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROCEDURES; RADIATION INJURIES; RADIOTHERAPY; RISK FACTOR; STANDARDS; CANCER RECURRENCE; CARDIAC IMAGING; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIUM SCORE; DONKEY; HEART INJURY; NONHUMAN; QUALITY OF LIFE;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; DIAGNOSTIC IMAGING; HUMANS; MULTIMODAL IMAGING; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIOTHERAPY; RISK FACTORS;

EID: 84905983542     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.06.007     Document Type: Review

References (117)

1. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management J Am Coll Cardiol 53 2009 2231 2247
2. A.C. Mertens, Q. Liu, and J.P. Neglia et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study J Natl Cancer Inst 100 2008 1368 1379
3. E.T. Yeh Cardiotoxicity induced by chemotherapy and antibody therapy Annu Rev Med 57 2006 485 498
4. N. Mewton, C.Y. Liu, and P. Croisille et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance J Am Coll Cardiol 57 2011 891 903
5. H.S. Gillespie, C.J. McGann, and B.D. Wilson Noninvasive diagnosis of chemotherapy related cardiotoxicity Curr Cardiol Rev 7 2011 234 244
6. D. Slamon, W. Eiermann, and N. Robert et al. Adjuvant trastuzumab in HER2-positive breast cancer N Engl J Med 365 2011 1273 1283
7. D.J. Slamon, B. Leyland-Jones, and S. Shak et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
8. R. Gupta, and M.L. Maitland Sunitinib, hypertension, and heart failure: a model for kinase inhibitor-mediated cardiotoxicity Curr Hypertens Rep 13 2011 430 435
9. M.A. Pantaleo, A. Mandrioli, and M. Saponara et al. Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib BMC Cancer 12 2012 231
10. T.F. Chu, M.A. Rupnick, and R. Kerkela et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib Lancet 370 2007 2011 2019
11. V. Ranpura, S. Hapani, J. Chuang, and S. Wu Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials Acta Oncol 49 2010 287 297
12. J.A. Chapman, D. Meng, and L. Shepherd et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer J Natl Cancer Inst 100 2008 252 260
13. M.S. Ewer, and S. Gluck A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health Cancer 115 2009 1813 1826
14. E. Amir, B. Seruga, S. Niraula, L. Carlsson, and A. Ocaña Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis J Natl Cancer Inst 103 2011 1299 1309
15. N.L. Keating, A.J. O'Malley, S.J. Freedland, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer J Natl Cancer Inst 102 2010 39 46
16. M. Van Hemelrijck, H. Garmo, and L. Holmberg et al. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden J Clin Oncol 28 2010 3448 3456
17. R.G. Schwartz, W.B. McKenzie, and J. Alexander et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: seven-year experience using serial radionuclide angiocardiography Am J Med 82 1987 1109 1118
18. L.F. de Geus-Oei, A.M. Mavinkurve-Groothuis, and L. Bellersen et al. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity J Nucl Med 52 2011 560 571
19. J.H. McKillop, M.R. Bristow, M.L. Goris, M.E. Billingham, and K. Bockemuehl Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity Am Heart J 106 1983 1048 1056
20. B. Hesse, T.B. Lindhardt, and W. Acampa et al. EANM/ESC guidelines for radionuclide imaging of cardiac function Eur J Nucl Med Mol Imaging 35 2008 851 885
21. Y. Cottin, C. Touzery, and B. Coudert et al. Impairment of diastolic function during short-term anthracycline chemotherapy Br Heart J 73 1995 61 64
22. A. Cochet, G. Quilichini, and I. Dygai-Cochet et al. Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer Breast Cancer Res Treat 130 2011 845 854
23. L.J. Steinherz, T. Graham, and R. Hurwitz et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group Pediatrics 89 1992 942 949
24. F.J. Klocke, M.G. Baird, and B.H. Lorell et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J Am Coll Cardiol 42 2003 1318 1333
25. P. Merlet, H. Valette, and J.L. Dubois-Rande et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471 477
26. T. Nakata, K. Miyamoto, and A. Doi et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts J Nucl Cardiol 5 1998 579 590
27. R.A. Valdes Olmos, W.W. ten Bokkel Huinink, and R.F. ten Hoeve et al. Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy Eur J Cancer 31A 1995 26 31
28. I. Carrió, M. Estorch, L. Berna, J. Lopez-Pousa, J. Tabernero, and G. Torres Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity J Nucl Med 36 1995 2044 2049
29. S. Wakasugi, A.J. Fischman, and J.W. Babich et al. Metaiodobenzylguanidine: evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy J Nucl Med 34 1993 1283 1286
30. T.J. Jeon, J.D. Lee, J.W. Ha, W.I. Yang, and S.H. Cho Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry Eur J Nucl Med 27 2000 686 693
31. T. Nousiainen, E. Vanninen, E. Jantunen, J. Remes, J. Kuikka, and J. Hartikainen Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake Clin Physiol 21 2001 123 128
32. M.D. Cheitlin, W.F. Armstrong, and G.P. Aurigemma et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) J Am Coll Cardiol 42 2003 954 970
33. F. Corapcioglu, N. Sarper, F. Berk, T. Sahin, E. Zengin, and H. Demir Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography Pediatr Hematol Oncol 23 2006 71 80
34. N. van Royen, C.C. Jaffe, and H.M. Krumholz et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 1996 843 850
35. J. Walker, N. Bhullar, and N. Fallah-Rad et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging J Clin Oncol 28 2010 3429 3436
36. L. Oreto, M.C. Todaro, and M.M. Umland et al. Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know? J Am Soc Echocardiogr 25 2012 1141 1152
37. H. Sawaya, I.A. Sebag, and J.C. Plana et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients Am J Cardiol 107 2011 1375 1380
38. K.A. Ammar, T.E. Paterick, and B.K. Khandheria et al. Myocardial mechanics: understanding and applying three-dimensional speckle tracking echocardiography in clinical practice Echocardiography 29 2012 861 872
39. M. Biswas, S. Sudhakar, and N.C. Nanda et al. Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions Echocardiography 30 2013 88 105
40. J.L. Dorosz, D.C. Lezotte, D.A. Weitzenkamp, L.A. Allen, and E.E. Salcedo Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis J Am Coll Cardiol 59 2012 1799 1808
41. H. Geyer, G. Caracciolo, and H. Abe et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications J Am Soc Echocardiogr 23 2010 351 369
42. C. Jenkins, S. Moir, J. Chan, D. Rakhit, B. Haluska, and T.H. Marwick Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging Eur Heart J 30 2009 98 106
43. F. Maffessanti, H.J. Nesser, and L. Weinert et al. Quantitative evaluation of regional left ventricular function using three-dimensional speckle tracking echocardiography in patients with and without heart disease Am J Cardiol 104 2009 1755 1762
44. J.A. Urbano-Moral, A.R. Patel, M.S. Maron, J.A. Arias-Godinez, and N.G. Pandian Three-dimensional speckle-tracking echocardiography: methodological aspects and clinical potential Echocardiography 29 2012 997 1010
45. Y.F. Cheung, S.N. Li, G.C. Chan, S.J. Wong, and S.Y. Ha Left ventricular twisting and untwisting motion in childhood cancer survivors Echocardiography 28 2011 738 745
46. K. Erven, A. Florian, and P. Slagmolen et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy Int J Radiat Oncol Biol Phys 85 2013 1172 1178
47. E. Ho, A. Brown, and P. Barrett et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study Heart 96 2010 701 707
48. H. Motoki, J. Koyama, and H. Nakazawa et al. Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy Eur Heart J Cardiovasc Imaging 13 2012 95 103
49. J.T. Poterucha, S. Kutty, R.K. Lindquist, L. Li, and B.W. Eidem Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction J Am Soc Echocardiogr 25 2012 733 740
50. P.W. Stoodley, D.A. Richards, and R. Hui et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy Eur J Echocardiogr 12 2011 945 952
51. M. Galderisi, F. Marra, R. Esposito, V.S. Lomoriello, M. Pardo, and O. de Divitiis Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography Cardiovasc Ultrasound 5 2007 4
52. J.K. Raikhelkar, R.M. Steingart, and C.L. Chen Role of echocardiography in cancer care Herz 36 2011 333 339
53. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, and branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
54. M. Martin, F.J. Esteva, and E. Alba et al. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations Oncologist 14 2009 1 11
55. A. Seidman, C. Hudis, and M.K. Pierri et al. Cardiac dysfunction in the trastuzumab clinical trials experience J Clin Oncol 20 2002 1215 1221
56. V.B. Pai, and M.C. Nahata Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention Drug Saf 22 2000 263 302
57. P. Thavendiranathan, A.D. Grant, T. Negishi, J.C. Plana, Z.B. Popovic, and T.H. Marwick Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 2013 77 84
58. M.F. Stoddard, J. Seeger, N.E. Liddell, T.J. Hadley, D.M. Sullivan, and J. Kupersmith Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans J Am Coll Cardiol 20 1992 62 69
59. S. Tassan-Mangina, D. Codorean, and M. Metivier et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study Eur J Echocardiogr 7 2006 141 146
60. B. Marchandise, E. Schroeder, and A. Bosly et al. Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics Am Heart J 118 1989 92 98
61. S.A. Lange, B. Ebner, and A. Wess et al. Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy Clin Res Cardiol 101 2012 415 426
62. H. Sawaya, I.A. Sebag, and J.C. Plana et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab Circ Cardiovasc Imaging 5 2012 596 603
63. K. Negishi, T. Negishi, and J.L. Hare et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity J Am So Echocardiogr 26 2013 493 498
64. P. Thavendirananthan, F. Poulin, K. Lim, J.C. Plana, A. Woo, and T.H. Marwick Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy-A systematic review J Am Coll Cardiol 63 2014 2751 2768
65. A. Fontana, A. Zambon, F. Cesana, C. Giannattasio, and G. Trocino Tissue Doppler, triplane echocardiography, and speckle tracking echocardiography: different ways of measuring longitudinal myocardial velocity and deformation parameters. A comparative clinical study Echocardiography 29 2012 428 437
66. S.L. Mulvaqh, H. Rakowski, and M.A. Vannan et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography J Am Soc Echocardiogr 11 2008 1179 1201
67. W.C. Little, and G.L. Freeman Pericardial disease Circulation 113 2006 1622 1632
68. J. Rademaker, H. Schoder, and N.S. Ariaratnam et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients AJR Am J Roentgenol 191 2008 32 37
69. S. Kupeli, T. Hazirolan, and A. Varan et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma J Clin Oncol 28 2010 1025 1030
70. S. Apter, J. Shemesh, and P. Raanani et al. Cardiovascular calcifications after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation Coron Artery Dis 17 2006 145 151
71. D.A. Mulrooney, M.W. Yeazel, and T. Kawashima et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort BMJ 339 2009 b4606
72. E.M. van Leeuwen-Segarceanu, W.J. Bos, and L.D. Dorresteijn et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease Cancer Treat Rev 37 2011 391 403
73. R. Andersen, T. Wethal, and A. Gunther et al. Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma Am J Cardiol 105 2010 149 152
74. C. Asferg, L. Usinger, T.S. Kristensen, and J. Abdulla Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis Eur J Radiol 81 2012 e757 e762
75. W.G. Hundley, D.A. Bluemke, and J.P. Finn et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2614 2662
76. S. Vasu, and W.G. Hundley Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance JCMR 15 2013 66
77. G.T. Armstrong, J.C. Plana, and N. Zhang et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 30 2012 2876 2884
78. T.G. Neilan, O.R. Coelho-Filho, and D. Pena-Herrera et al. Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines Am J Cardiol 110 2012 1679 1686
79. N. Fallah-Rad, J.R. Walker, and A. Wassef et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy J Am Coll Cardiol 57 2011 2263 2270
80. B.C. Drafts, K.M. Twomley, and R. D'Agostino Jr. et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease CME J Am Coll Cardiol Img 6 2013 877 885
81. R.S. Jiji, C.M. Kramer, and M. Salerno Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs J Nucl Cardiol 19 2012 377 388
82. K. Oberholzer, R.P. Kunz, M. Dittrich, and M. Thelen Anthrazyklin- induzierte Kardiotoxizität: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer] Rofo 176 2004 1245 1250
83. F. Bonner, M. Neizel, S. Gruenig, C. Jacoby, M. Kelm, and B. Sievers T2 mapping in different cardiomyopathies: first clinical experience J Cardiovasc Magn Reson 15 Suppl 1 2013 P53
84. J.C. Lightfoot, R.B. D'Agostino Jr., and C.A. Hamilton et al. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model Circ Cardiovasc Imaging 3 2010 550 558
85. R. Wassmuth, S. Lentzsch, and U. Erdbruegger et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - a pilot study Am Heart J 141 2001 1007 1013
86. E. Tham, K. Chow, M. Spavor, J. Pagano, M. Haykowsky, and R. Thompson Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy J Cardiovasc Magn Reson 13 Suppl 1 2011 P276
87. O. Catalano, S. Antonaci, G. Moro, M. Baldi, F. Cobelli, and C. Opasich Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy J Cardiovasc Med (Hagerstown) 8 2007 214 215
88. L.W. Dobrucki, and A.J. Sinusas Cardiovascular molecular imaging Semin Nucl Med 35 2005 73 81
89. V. Bittner, R.C. Reeves, S.B. Digerness, J.B. Caulfield, and G.M. Pohost 31P NMR spectroscopy in chronic adriamycin cardiotoxicity Magn Reson Med 17 1991 69 81
90. N. Chaosuwannakit, R. D'Agostino Jr., and C.A. Hamilton et al. Aortic stiffness increases upon receipt of anthracyclin chemotherapy J Clin Oncol 28 2010 166 172
91. Z. Jenei, E. Bardi, M.T. Magyar, A. Horvath, G. Paragh, and C. Kiss Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer Pathol Oncol Res 19 2013 375 383
92. C.D. Wiginton, B. Kelly, and A. Oto et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue AJR Am J Roentgenol 190 2008 1060 1068
93. E.C. Korngold, F.A. Jaffer, R. Weissleder, and D.E. Sosnovik Noninvasive imaging of apoptosis in cardiovascular disease Heart Fail Rev 13 2008 163 173
94. A.R. Morrison, and A.J. Sinusas New molecular imaging targets to characterize myocardial biology Cardiol Clin 27 2009 329 344
95. R.J. Bennink, M.J. van den Hoff, and F.J. van Hemert et al. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats J Nucl Med 45 2004 842 848
96. K.L. Gabrielson, G.S. Mok, and S. Nimmagadda et al. Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography Mol Imaging 7 2008 132 138
97. G.S. Panjrath, V. Patel, C.I. Valdiviezo, N. Narula, J. Narula, and D. Jain Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model J Am Coll Cardiol 49 2007 2457 2464
98. D.E. Sosnovik, E.A. Schellenberger, and M. Nahrendorf et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle Magn Reson Med 54 2005 718 724
99. M. Ueno, Y. Kakinuma, and K. Yuhki et al. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo J Pharmacol Sci 101 2006 151 158
100. D. Zhou, W. Chu, and J. Rothfuss et al. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis Bioorg Med Chem Lett 16 2006 5041 5046
101. R.A. Valdes Olmos, I. Carrio, and C.A. Hoefnagel et al. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction Nucl Med Commun 23 2002 871 877
102. C.L. Maini, R. Sciuto, and A. Ferraironi et al. Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity J Nucl Cardiol 4 1997 502 508
103. T. Dobrucki Dekker, C.J. van Echteld, and J.H. Kirkels et al. Chronic cardiotoxicity of adriamycin studied in a rat model by 31P NMR NMR Biomed 4 1991 16 24
104. K. Saito, K. Takeda, K. Imanaka-Yoshida, H. Imai, T. Sekine, and Y. Kamikura Assessment of fatty acid metabolism in taxan-induced myocardial damage with iodine-123 BMIPP SPECT: comparative study with myocardial perfusion, left ventricular function, and histopathological findings Ann Nucl Med 17 2003 481 488
105. K. Saito, K. Takeda, and S. Okamoto et al. Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method J Nucl Cardiol 7 2000 553 561
106. G.P. Carboni A novel clinical indicator using cardiac technetium-99m sestamibi kinetics for evaluating cardiotoxicity in cancer patients treated with multiagent chemotherapy Am J Cardiovasc Dis 2 2012 293 300
107. C. Borde, P. Kand, and S. Basu Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: evidence of early chemotherapeutic cardiotoxicity? World J Radiol 4 2012 220 223
108. M.E. Toubert, L. Vercellino, I. Faugeron, D. Lussato, E. Hindie, and G. Bousquet Fatal heart failure after a 26-month combination of tyrosine kinase inhibitors in a papillary thyroid cancer Thyroid 21 2011 451 454
109. W. Cai, and X. Chen Multimodality molecular imaging of tumor angiogenesis J Nucl Med 49 Suppl 2 2008 113S 128S
110. M.R. Stacy, M.W. Maxfield, and A.J. Sinusas Targeted molecular imaging of angiogenesis in PET and SPECT: a review Yale J Biol Med 85 2012 75 86
111. T.M. Behr, M. Behe, and B. Wormann Trastuzumab and breast cancer N Engl J Med 345 2001 995 996
112. P.J. Perik, M.N. Lub-De Hooge, and J.A. Gietema et al. Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer J Clin Oncol 24 2006 2276 2282
113. M.A. de Korte, E.G. de Vries, and M.N. Lub-de Hooge et al. 111-Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity Eur J Cancer 43 2007 2046 2051
114. P. Lancellotti, V.T. Nkomo, and L.P. Badano et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography Eur Heart J Cardiovasc Imaging 14 2013 721 740
115. S.E. Lipshultz, M.J. Adams, and S.D. Colan Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement for the American Heart Association Circulation 128 2013 1927 1995
116. P.J. Barrett-Lee, J.M. Dixon, and C. Farrell et al. Expert opinion of the use of anthracyclines in patients with advanced breast cancer at cardiac risk Ann Oncol 20 2009 816 827
117. E. Raschi, and F. De Ponti Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology Intern Emerg Med 7 2012 113 131